Project Grant R01GM157622
Award Date
7/1/25
Completion Date
3/31/29
Dollars Obligated
$349K
Federal Agency
National Institute of General Medical Sciences
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
Penn State University, PA 16802, USA
Similar Awards
The National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training Program (CFDA 93.859), awarded a $401,253 Project Grant to The Pennsylvania State University ("Penn State") effective February 1, 2025 through November 30, 2029. The grant supports research to elucidate novel cyclic nucleotide signaling pathways and physiological effects in bacteria, with a focus on understanding the molecular mechanisms controlling 2',3'-cyclic nucleotide...
This National Science Foundation (NSF) Biological Sciences program (CFDA 47.074) award provides $776,309 to The Pennsylvania State University for a project titled "CARBON-DETECTED NMR STUDIES OF INTRINSICALLY DISORDERED PROTEINS IN PROMOTER PROXIMAL PAUSING." The project aims to push the boundaries of current nuclear magnetic resonance (NMR) spectroscopy technologies to explore the structural responses to chemical modifications that trigger the release of RNA polymerase II from pausing...
This $450,313 federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) supports research to understand the molecular mechanisms and structural dynamics underlying multidomain enzymatic factories known as nonribosomal peptide synthetases (NRPSs). The research team at The Johns Hopkins University will leverage nuclear magnetic resonance (NMR) spectroscopy and computational approaches to determine...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859) supports advanced microscopy techniques to study the spatial organization and dynamics of cellular components. The $852,726 award will fund research to elucidate how molecular assemblies regulate organelle transport and positioning, how organelle identity links to positioning and function, and the relationship between chromatin...
The National Institute of General Medical Sciences (NIGMS) awarded a $299,978 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to Lifesensors Inc., a biotechnology company located in Malvern, Pennsylvania. The award, effective from September 1, 2024 to August 31, 2025, supports the development of novel molecular glue degraders targeting the LRRK2 protein, which is associated with Parkinson's disease. The project aims to create a high-throughput...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training Program (CFDA 93.859), provides $479,924 to The Pennsylvania State University to conduct research on how RNA structure regulates gene expression in bacteria. Key focus areas include understanding the roles of the transcription elongation factors NusA and NusG in controlling pausing and termination of RNA polymerase, as well as investigating how the...
This Project Grant award for $380,540, awarded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859), supports research to decipher novel principles of rapid proteostatic control and develop spatiotemporal lysosomal tools. The research aims to define new protein substrates and peptide motifs required for lysosomal delivery, determine the functional impact of methyl-driven lysosomal proteolysis on cellular metabolic...
The National Institute of General Medical Sciences (NIGMS) awarded a $1,433,731 Project Grant (CFDA 93.859 - Biomedical Research and Research Training) to The Pennsylvania State University (Penn State) to develop an innovative method for aptamer selection and truncation, and to examine the efficiency of in vivo aptamer delivery for regulating inflammation. The 4-year project, starting on September 1, 2024, will focus on four specific aims: (1) aptamer selection, (2) aptamer truncation, (3)...
This Project Grant award, provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859), is funding research to elucidate the molecular mechanisms underlying the impact of protein arginine methylation on gene expression. The $445,000 award, effective January 23, 2025 through December 31, 2029, aims to address three key research objectives: 1) understanding how arginine methylation impacts cellular m6A...
The National Institute of General Medical Sciences (NIGMS) awarded a $350,000 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to Electronic Biosciences, Inc., a small biotechnology company in San Diego, California. The purpose of this grant is to develop and demonstrate a novel enzyme-based, single-molecule protein sequencing system. This innovative platform will leverage enzymatic processing and advanced bioinformatics to accurately sequence peptides with...